Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: NFAT2 overexpression suppresses the malignancy of hepatocellular carcinoma through inducing Egr2 expression

Fig. 4

The mRNA and protein expression of NFAT2, Egr2, FasL, COX-2 and c-myc in hepatic carcinoma tissues and adjacent nontumor tissues. a The mRNA expression of NFAT2, Egr2, FasL, COX-2 and c-myc in hepatic carcinoma tissues and adjacent nontumor tissues (n = 20). b The protein expression of NFAT2, Egr2, FasL, COX-2 and c-myc in hepatic carcinoma tissues and adjacent nontumor tissues (n = 20). Each bar represents the mean ± S.D.; *p < 0.05, **p < 0.01, ***p < 0.001 compared to the carcinoma tissue samples. Full-length blots are presented in Supplementary Figures. c The representative images of immunohistochemical staining for NFAT2 in hepatic carcinoma tissue and adjacent nontumor tissue (Magnification, 200×).

Back to article page